US$ 23.32
semaglutide lilly Novo Nordisk shares down after analysis finds drug leads to better weight loss Novo Nordisk's semaglutide gains ground
Description
Semaglutide is an FDA-approved medication designed to support weight loss by reducing appetite and enhancing feelings of fullness
It contains the active ingredient liraglutide, which works by mimicking the naturally occurring hormone GLP-1

GLP-1 RAs were created after endogenous glucagon-like peptide-1 (GLP-1) was discovered in the 1980s by Jens Juul Host and Joel Habener [1,2]

, ,

By acting early, we help you prevent heart attack, stroke, and loss of vitality
TRIUMPH-4 weight loss results at 68 weeks Source: Eli Lilly press release, December 2025
